Declining COVID-19 vaccination coverage in Brazil: A global health warning - 13/02/25
Doi : 10.1016/j.jinf.2025.106418
Milena Silva Souza
Center of Biological Sciences and Health, Western Bahia Virology Institute, Federal University of Western Bahia, Barreiras, Bahia, Brazil
Department of Biological Sciences, Graduate Program in Biology and Biotechnology of Microorganisms, State University of Santa Cruz, Ilhéus, Bahia, Brazil
Jéssica Pires Farias, Luís Carlos de Souza Ferreira
Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, Sao Paulo, SP, Brazil
Jaime Henrique Amorim ⁎ 
Center of Biological Sciences and Health, Western Bahia Virology Institute, Federal University of Western Bahia, Barreiras, Bahia, Brazil
Department of Biological Sciences, Graduate Program in Biology and Biotechnology of Microorganisms, State University of Santa Cruz, Ilhéus, Bahia, Brazil
∗Correspondence to: Western Bahia Virology Institute, Center of Biological Sciences and Health, Federal University of Western Bahia, Rua da Prainha, 1326, Morada Nobre, Barreiras, Bahia CEP 47810-047, Brazil.Western Bahia Virology Institute, Center of Biological Sciences and Health, Federal University of Western BahiaRua da Prainha, 1326, Morada NobreBarreirasBahiaCEP 47810-047Brazil
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Global COVID-19 vaccination rates drop, with Brazil showing concerning trends. |
• | Omicron subvariants challenge vaccine efficacy, emphasizing the need for updates. |
• | Under 1% of Brazilians received the new XBB.1.5 monovalent vaccine in 2024. |
• | Vaccine hesitancy in Brazil linked to logistical, cultural, and informational barriers. |
• | Equity in vaccine access and surveillance is crucial for global health security. |
© 2025
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 2
Article 106418- février 2025 Retour au numéro
Article précédent
- High-copy IncP-2 megaplasmid carrying blaAFM in clinical difficult-to-treat resistance Pseudomonas aeruginosa: Associated with high-level cefiderocol resistance
- Wenhao Wu, Meijun Song, Xi Li, Piaopiao Zhang, Yue Li, Heng Cai, Yan Jiang, Yunsong Yu, Tingting Qu
- Is the pathogen spectrum of encephalitis/meningitis changing in China?
- Ruichen Wang, Qikai Yin, Kai Nie, Fan Li, Shihong Fu, Qianqian Cui, Han Chen, Songtao Xu, Huanyu Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.